Leave Your Message
Engineered to meet British Pharmacopoeia (BP) and United States Pharmacopeia (USP) standards, tailored for the fast-growing clinical and therapeutic manufacturing landscape of Bangladesh.
An in-depth look into thyroid disorder prevalence, domestic formulation manufacturing, and API supply chain integration in South Asia's vibrant pharmaceutical hub.
Bangladesh, home to over 170 million people, is undergoing a major demographic and epidemiological transition. While historically focused on acute infectious diseases, the healthcare system is now confronting a dramatic rise in non-communicable chronic conditions, among which endocrine disorders—specifically thyroid dysfunctions—represent an urgent and widespread public health challenge.
Clinical studies across Dhaka, Chittagong, Sylhet, and Rajshahi indicate a substantial prevalence of subclinical and overt hypothyroidism, thyroiditis (including Hashimoto's thyroiditis), and congenital hypothyroidism in pediatric populations. Women of reproductive age and elderly demographics exhibit the highest vulnerability. The historic prevalence of iodine deficiency disorders (IDD) across the northern riverine delta has transitioned into complex autoimmune and metabolic thyroid conditions, making Levothyroxine Sodium (T4) therapy a daily, life-sustaining requirement for millions of Bangladeshi citizens.
Clinical Criticality: Levothyroxine Sodium is a narrow therapeutic index (NTI) synthetic levorotatory isomer of thyroxine. Even microgram variations in dosage (25 µg, 50 µg, 75 µg, 88 µg, 100 µg) have profound clinical consequences on cardiac output, basal metabolic rate, and cognitive development in neonates.
The pharmaceutical industry of Bangladesh is one of the most technologically advanced and self-sufficient sectors in the developing world, fulfilling over 98% of domestic finished formulation requirements and exporting to more than 150 countries. Renowned pharmaceutical leaders in Gazipur, Savar, Tongi, and Bhaluka operate modern cGMP facilities accredited by stringent regulatory authorities like US FDA, UK MHRA, EU GMP, and WHO-Geneva.
However, despite world-class finished oral solid dosage (OSD) manufacturing capacity, the local industry remains heavily reliant on imported Active Pharmaceutical Ingredients (APIs) for highly potent, low-dose molecules like Levothyroxine Sodium. Sourcing consistent, ultra-pure, crystal-stable Levothyroxine Sodium API with uniform particle size distribution is paramount for Bangladeshi formulation chemists to ensure accurate content uniformity and prevent batch recalls under the Directorate General of Drug Administration (DGDA) quality vigilance.
Jiangxi Serum Pharma Industries Co., Ltd. is a professional supplier of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives, and plant extracts, and have accumulated rich industry experience.
With an unwavering commitment to quality assurance, regulatory documentation (DMF, CTD dossiers, GMP certificates, CoAs), and tailored logistics solutions for South Asian trade corridors, we provide Bangladeshi pharmaceutical conglomerates with stable, high-potency molecules that meet international standards.
Established in 2017
Long-Term Cooperation Clients
Close-Related Suppliers
Annual Sales Exceeding USD
Levothyroxine Sodium is inherently susceptible to photodegradation, moisture sorption, and oxidation. Formulating this molecule for Bangladesh's Climatic Zone IVb (30°C / 75% RH) requires cutting-edge particle engineering and excipient synergy.
Because Levothyroxine tablets contain as little as 25 µg to 100 µg of active substance per tablet, direct compression blend uniformity is critical. Our API is micronized with laser diffraction d90 < 15 µm to ensure homogeneous distribution in microcrystalline cellulose and calcium phosphate matrices.
Bangladesh experiences high temperatures and monsoon humidity. We supply Levothyroxine Sodium with tight moisture specifications (water content ≤ 10.5% hydrate crystal integrity) and support local manufacturers with Alu-Alu blister packaging protocols and stability data packages for DGDA submissions.
Strict control of Levothyroxine degradation pathways—including 3,5-diiodo-L-thyronine (T2), Liothyronine (T3), and related isomers. Fully validated HPLC impurity assays ensure compliance with USP/BP limits, safeguarding patients against fluctuating bioavailability.
In Bangladeshi clinical practice, Levothyroxine Sodium is a core constituent of national essential medicine formularies. It is deployed across multiple specialized medical tiers:
1. Maternal and Fetal Health Programs: Subclinical hypothyroidism during pregnancy is closely linked to increased risks of miscarriage, gestational hypertension, and neurodevelopmental deficits in offspring. Leading obstetric clinics in Dhaka Medical College Hospital (DMCH), Bangabandhu Sheikh Mujib Medical University (BSMMU), and district maternal healthcare centers rely on consistent T4 dosing to maintain target TSH levels during all trimesters.
2. Pediatric Congenital Hypothyroidism Screening: Early intervention within the first weeks of neonatal life prevents irreversible cretinism and mental retardation. Pediatric oral liquid pre-mixes and dispersible micro-tablets manufactured with our high-solubility Levothyroxine Sodium provide precise dosing for pediatric specialists across Bangladesh.
3. Post-Thyroidectomy & Oncology Management: For patients undergoing partial or total thyroidectomy due to multinodular goiter or papillary thyroid carcinoma at the National Institute of Cancer Research & Hospital (NICRH), high-dose Levothyroxine suppression therapy is administered to suppress pituitary TSH secretion and inhibit tumor recurrence.
Our pharmaceutical products consist of biological products, vaccines, western medicines, raw material, intermediates, medical consumables, with high quality and affordable prices.
From vital cardiovascular injectables to specialized metabolic regulators and cephalosporin antibiotics, we provide robust supply resilience to Bangladeshi generic formulators located in Gazipur, Savar, Tongi, and Chittagong Special Economic Zones.
Our nutritional ingredients cover several categories as plant extracts, plant oils & proteins, probiotics and other specialties, we are committed to exploring more health ingredients to support people’s health.
In Bangladesh, nutraceuticals and dietary supplements (such as selenium, zinc, and specialized probiotics) are increasingly co-prescribed with Levothyroxine to support gut-thyroid axis equilibrium and reduce autoimmune antibody titers.
Serum Pharma will continuously monitor the development of the cutting-edge markets, Currently, we have already cooperated with our partners on the customization of Pre-Mix, Co-Crystallization and Bio-Fermentation products service, and have launched corresponding support services, Details are as below:
Tailored micro-dose Levothyroxine and excipient co-processed pre-mixes enabling direct compression, eliminating content uniformity risks for high-speed tablet presses in Bangladesh plants.
Read More
Novel crystal engineering techniques that dramatically enhance the thermal stability, dissolution profile, and hygroscopic resistance of sensitive pharmaceutical active ingredients.
Read More
Next-generation biological fermentation systems for enzyme-assisted biosynthesis, specialized probiotics, and high-yield biopharmaceutical intermediates.
Read MoreStay informed on global pharmaceutical developments, raw material supply dynamics, and clinical breakthrough analyses relevant to Asian and international markets.
An extensive industrial overview examining the rapid transition from marine-derived squalene to sustainable, high-purity plant-based squalene for high-end pharmaceutical emulsions and vaccine adjuvant delivery.
Exploring the indispensable therapeutic value of Dexamethasone Sodium Phosphate API across emergency anti-inflammatory therapy, respiratory distress, and ongoing hospital critical care protocols.
Comprehensive evaluation of small-molecule GLP-1 oral receptor agonists, rapid approval mechanisms, metabolic benefits, and implications for global metabolic syndrome treatments.
Full spectrum of pharmaceutical solutions supplied to Bangladesh, Asia, and worldwide healthcare sectors under strict GMP, BP, and USP compliance.
